PhytoHealth Corporation (TPE:4108)

Market Cap	2.06B -26.6%
Revenue (ttm)	143.43M +3.6%
Net Income	-43.37M
EPS	-0.22
Shares Out	198.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	252,364
Open	10.70
Previous Close	10.60
Day's Range	10.30 - 10.75
52-Week Range	10.00 - 15.25
Beta	0.37
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 16, 2026

About PhytoHealth

PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. The Medical Diagnosis segment develops and sells smart medical imaging diagnostic products. The Precision Medical Equipment and Instruments segment eng...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 84
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4108

Financial Performance

In 2025, PhytoHealth's revenue was 134.58 million, a decrease of -12.36% compared to the previous year's 153.56 million. Losses were -58.20 million, -20.82% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error